Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
155.72 USD145.54 USD182.49 USD
+192%
145.54 USDCurrent price is 191.9% above the base model value.
V
US
VRTX.US · VERTEX PHARMACEUTICALS INC / MA
US · US
Latest price424.86 USD
30D+8.68%
Vs. base value+192%
Research summary
VRTX.US latest organized financial period shows revenue lacks a complete YoY comparison and net income grew +838% YoY. Current price is about 425 USD, while the model base case is about 146 USD; the current price sits +192% versus the base case. No structured non-recurring items are identified, so valuation defaults to reported figures. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue-
Net income4B USD
Free cash flow3B USD
Operating cash flow4B USD
Price trend
Price date: 2026/04/29 · Updated: 2026/04/29 15:23
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price424.86 USD
Base value145.54 USD
Vs. base+192%
Price date2026/04/29
155.72 USD145.54 USD182.49 USD
+192%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
281.43 USD384.90 USD457.92 USD
+10.38%
384.90 USDCurrent price is 10.4% above the base model value.
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth12.1%
Current price implies roughly 12.1% annualized FCF growth.
12.1%Current price implies roughly 12.1% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
139.61 USD139.61 USD139.61 USD
+204%
139.61 USDCurrent price is 204.3% above the base model value.
Updated: 2026/04/29 15:23
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
ExpandCollapse
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
No structured non-recurring items identified. Valuation currently defaults to reported figures and does not claim one-time gains have been removed.
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 14
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | - | 4B USD | - | 3B USD | 15.32 | - |
| 2024/12/31 | Annual | - | -536M USD | - | -790M USD | -2.08 | - |
| 2023/12/31 | Annual | - | 4B USD | - | 3B USD | 13.89 | - |
| 2022/12/31 | Annual | - | 3B USD | - | 4B USD | 12.82 | - |
| 2021/12/31 | Annual | - | 2B USD | - | 2B USD | 9.01 | - |
Ad placement